1. Pharmacological properties of colloidal bismuth subcitrate CBS (De-Nol);Wieriks, J.; Hespe, W.; Jaitly, K.D.; Koekkoek, P.H.; Lavy, U.;Sceand J Gastroenterol
2. Experimental studies using colloidal bismuth subcitrate: possible mode of action;Coghill, S.,1985
3. Pyloric campylobacter infection and gastroduodenal diseases;Med J Aus,1985
4. Advances in the understanding of the mechanism of cytoprotective action of colloidal bismuth subcitrate;Konturek, S.J.; Radecki, T.; Piastucki, I.; Drozdowicz, D.;Scand J Gastroenterol
5. Sucralfate. bismuth compounds substituted benzimidazoles, trimipramine and pirenzepine in the short and long-term treatment of duodenal ulcer;W, Tytgat G.N.J.Hameeteman; GW, Van Olffen;Clin Gastroenterol,1984